PAVM – pavmed inc. (US:NASDAQ)
Stock Stats
News
PAVmed Inc. (NASDAQ: PAVM) had its price target lowered by analysts at Ascendiant Capital Markets from $21.00 to $19.00. They now have a "buy" rating on the stock.
Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test [Yahoo! Finance]
Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum [Yahoo! Finance]
PAVmed Inc (PAVM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Restructuring [Yahoo! Finance]
PAVmed Inc. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
Form S-3 PAVmed Inc.
Form 144 PAVmed Inc. Filed by: Cox James L
Form 144 PAVmed Inc. Filed by: Cox James L
Form 144 PAVmed Inc. Filed by: Cox James L
Form DEF 14A PAVmed Inc. For: Dec 06
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.